Covaxin "Effectively Neutralises" Delta Variant, Says Top US Health Institute

  • 3:17
  • Published On: June 30, 2021
Cinema View
Embed
The US' National Institute of Health has said that India's Covaxin, developed by Bharat Biotech, effectively neutralises both Alpha and Delta variants of coronavirus. NDTV discusses the findings of this study.

Related Videos

Free Covid Booster Dose For All Adults From Today For Next 75 Days
July 15, 2022 4:03
Corbevax Cleared As Covid Booster Shot For 18 And Above
June 04, 2022 0:50
3 Indian Vaccines Approved For Use On Children
April 27, 2022 3:35
Covaxin Cleared For 6-12 Age Group
April 26, 2022 2:47
No Doubts On Safety, Efficacy: WHO Chief Scientist On Covaxin Suspension
April 21, 2022 16:44
Private Hospitals In Delhi, Tamil Nadu Yet To Slash Covid Vaccine Prices
April 10, 2022 3:20
Paid Boosters For All Adults From Today
April 10, 2022 4:00
Few Takers For Precautionary Dose At Private Hospitals In Chennai
April 10, 2022 3:37
Covishield, Covaxin Prices Cut To Rs. 225
April 10, 2022 4:04
Covishield, Covaxin Prices Cut To Rs 225 Day Before Booster Drive Begins
April 09, 2022 3:57
WHO Suspends UN Supply Of Covaxin; No Impact On Efficacy: Bharat Biotech
April 03, 2022 0:37
Late BJP Leader, Singer Sonu Nigam, Covaxin Maker Among 55 Padma Awardees
March 28, 2022 0:37
Our Offerings: NDTV
  • मध्य प्रदेश
  • राजस्थान
  • इंडिया
  • मराठी
  • 24X7
Choose Your Destination